2021 Full Year Investor Presentation
Filed with ASX · · 30 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26
The information provided is general in nature and is in summary form only. It is not complete and should be read in conjunction with the company’s audited Financial Statements and market disclosures. This material is not intended to be relied upon as advice to investors or potential investors. Non-IFRS information ● Other than as indicated, the financial information contained in this document is d
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- Class action proceeding
- FDA approval of novel oral contraceptive NEXTSTELLIS
- 2021 Half Year Investor Presentation
- 2021 Half Year Media Release
- Chairman and CEOs Addresses to Shareholders
Later from Mayne Pharma
- 2021 Full Year Media Release
- 2021 Mayne Pharma AGM Speeches
- Mayne Pharma expands US dermatology portfolio
- 2022 Half Year Investor Presentation
- Mayne Pharma reports 1HFY22 results
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma